BlackRock Advisors LLC raised its stake in Opko Health Inc. (NYSE:OPK) by 305.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 817,637 shares of the company’s stock after buying an additional 616,140 shares during the period. BlackRock Advisors LLC owned approximately 0.15% of Opko Health worth $7,637,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. California State Teachers Retirement System increased its position in Opko Health by 6.1% in the second quarter. California State Teachers Retirement System now owns 682,157 shares of the company’s stock valued at $6,371,000 after buying an additional 39,160 shares during the last quarter. Teachers Advisors Inc. increased its position in Opko Health by 3.6% in the first quarter. Teachers Advisors Inc. now owns 325,172 shares of the company’s stock valued at $3,379,000 after buying an additional 11,403 shares during the last quarter. Bank of New York Mellon Corp increased its position in Opko Health by 3.7% in the second quarter. Bank of New York Mellon Corp now owns 1,343,344 shares of the company’s stock valued at $12,547,000 after buying an additional 47,942 shares during the last quarter. BlackRock Group LTD increased its position in Opko Health by 19.1% in the first quarter. BlackRock Group LTD now owns 251,817 shares of the company’s stock valued at $2,616,000 after buying an additional 40,321 shares during the last quarter. Finally, Jaffetilchin Investment Partners LLC increased its position in Opko Health by 1.2% in the second quarter. Jaffetilchin Investment Partners LLC now owns 450,450 shares of the company’s stock valued at $4,207,000 after buying an additional 5,182 shares during the last quarter.
Shares of Opko Health Inc. (NYSE:OPK) opened at 9.56 on Thursday. The company’s 50-day moving average price is $10.06 and its 200 day moving average price is $10.08. The stock has a market cap of $5.26 billion and a price-to-earnings ratio of 40.00. Opko Health Inc. has a 12-month low of $7.12 and a 12-month high of $11.85.
Opko Health (NYSE:OPK) last released its quarterly earnings data on Monday, August 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The business had revenue of $357.10 million for the quarter, compared to analyst estimates of $324.11 million. The company’s revenue was up 742.2% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.09) earnings per share. On average, equities analysts predict that Opko Health Inc. will post ($0.05) earnings per share for the current year.
Several brokerages have recently issued reports on OPK. JPMorgan Chase & Co. set a $14.00 price objective on Opko Health and gave the stock a “buy” rating in a report on Tuesday, August 9th. Zacks Investment Research cut Opko Health from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Deutsche Bank AG decreased their price objective on Opko Health from $11.00 to $10.00 and set a “hold” rating on the stock in a report on Thursday, June 16th. Standpoint Research upped their price objective on Opko Health from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, June 21st. Finally, Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Opko Health in a report on Thursday, June 16th. Five investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $13.20.
In other news, CEO Phillip Md Et Al Frost bought 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was purchased at an average cost of $9.88 per share, with a total value of $98,800.00. Following the transaction, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $30,321,235.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
About Opko Health
OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.
Want to see what other hedge funds are holding OPK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Opko Health Inc. (NYSE:OPK).
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.